Tumor and immune determinants of response to anti-BCMA CAR T-cell therapy in multiple myeloma using cell-free DNA

被引：0
|
作者：
Carleton, Mia
Hosoya, Hitomi
Tanaka, Kailee L.
Sworder, Brian
Hovanky, Vanna
Sahaf, Bita
Frank, Matthew J.
Duran, George E.
Zhang, Tian Y.
Arai, Sally
Iberri, David
Liedtke, Michaela
Miklos, David B.
Khodadoust, Michael S.
Sidana, Surbhi
Kurtz, David M.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-5707
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5707
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Anti-BCMA CAR T-Cell Therapy in Multiple Myeloma
    Quintas-Cardama, Alfonso
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (03):
  • [2] Anti-BCMA CAR T-cell Therapy Reins in Myeloma
    Dolgin, Elie
    CANCER DISCOVERY, 2019, 9 (07) : 817 - 819
  • [3] The Safety of Bridging Radiation with Anti-BCMA CAR T-Cell Therapy for Multiple Myeloma
    Manjunath, Shwetha H.
    Cohen, Adam D.
    Lacey, Simon F.
    Davis, Megan M.
    Garfall, Alfred L.
    Melenhorst, J. Joseph
    Maxwell, Russell
    Arscott, W. Tristram
    Maity, Amit
    Jones, Joshua A.
    Plastaras, John P.
    Stadtmauer, Edward A.
    Levine, Bruce L.
    June, Carl H.
    Milone, Michael C.
    Paydar, Ima
    CLINICAL CANCER RESEARCH, 2021, 27 (23) : 6580 - 6590
  • [4] Anti-BCMA CAR T-cell Therapy: Changing the Natural History of Multiple Myeloma
    Puertas, Borja
    Mateos, Maria-Victoria
    Gonzalez-Calle, Veronica
    HEMASPHERE, 2022, 6 (03):
  • [5] Humoral immune reconstitution after anti-BCMA CAR T-cell therapy in relapsed/refractory multiple myeloma
    Wang, Ying
    Li, Chunrui
    Xia, Jieyun
    Li, Ping
    Cao, Jiang
    Pan, Bin
    Tan, Xu
    Li, Hujun
    Qi, Kunming
    Wang, Xiangmin
    Shi, Ming
    Jing, Guangjun
    Yan, Zhiling
    Cheng, Hai
    Zhu, Feng
    Sun, Haiying
    Sang, Wei
    Li, Depeng
    Zhang, Xi
    Li, Zhenyu
    Zheng, Junnian
    Liang, Aibin
    Zhou, Jianfeng
    Xu, Kailin
    BLOOD ADVANCES, 2021, 5 (23) : 5290 - 5299
  • [6] Anti-BCMA CAR T-cell therapy in multiple myeloma: can we do better?
    D'Agostino, Mattia
    Raje, Noopur
    LEUKEMIA, 2020, 34 (01) : 21 - 34
  • [7] Anti-BCMA CAR T-cell therapy in multiple myeloma: can we do better?
    Mattia D’Agostino
    Noopur Raje
    Leukemia, 2020, 34 : 21 - 34
  • [8] Monitoring anti-BCMA CAR T-Cell Therapy with bb2121 in relapsed multiple myeloma
    Seipel, K.
    Wiedemann, G.
    Jeker, B.
    Porret, N.
    Taleghani, B. Mansouri
    Bacher, U.
    Pabst, T.
    SWISS MEDICAL WEEKLY, 2021, 151 : 24 - 24
  • [9] Biallelic Loss of BCMA Triggers Resistance to Anti-BCMA CAR T Cell Therapy in Multiple Myeloma
    Samur, Mehmet K.
    Fulciniti, Mariateresa
    Aktas-Samur, Anil
    Bazarbachi, Abdul Hamid
    Tai, Yu-Tzu
    Campbell, Timothy B.
    Petrocca, Fabio
    Hege, Kristen
    Kaiser, Shari
    Anderson, Kenneth
    Munshi, Nikhil C.
    BLOOD, 2020, 136
  • [10] Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
    Raje, Noopur
    Berdeja, Jesus
    Lin, Yi
    Siegel, David
    Jagannath, Sundar
    Madduri, Deepu
    Liedtke, Michaela
    Rosenblatt, Jacalyn
    Maus, Marcela V.
    Turka, Ashley
    Lam, Lyh-Ping
    Morgan, Richard A.
    Friedman, Kevin
    Massaro, Monica
    Wang, Julie
    Russotti, Greg
    Yang, Zhihong
    Campbell, Timothy
    Hege, Kristen
    Petrocca, Fabio
    Quigley, M. Travis
    Munshi, Nikhil
    Kochenderfer, James N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (18): : 1726 - 1737
12345